news
Taking a standard prostate cancer drug with food boosts impact
By taking Zytiga with a low-fat meal could decrease the daily dose and prevent digestive issues...
List view / Grid view
Emory University
news
Is extended-release guanfacine effective in children with chronic tic disorders?
A new study has assessed the safety, tolerability, and effectiveness of extended-release guanfacine in children 6-17 years of age who have chronic tic disorders including Tourette's disorder.
news
Microneedle patches for flu vaccination prove successful in first human clinical trial
Small skin patches with dissolvable microneedles were safe and well-tolerated, generated robust immunity against influenza, could be self-administered by study participants and were strongly preferred over shots.
news
Pioneering treatment could freeze out phantom limb pain
6 April 2016 | By Victoria White
Cryoablation therapy, a targeted treatment using cold blasts, shows promise in improving the quality of life for patients suffering phantom limb pain...
article
Can mTOR kinase inhibitors beat rapalogues in fighting against cancer?
The mammalian target of rapamycin (mTOR) has emerged as a promising cancer therapeutic target. Some rapamycin analogues (rapalogues) as mTOR allosteric inhibitors are FDA-approved drugs for treatment of certain types of cancers. However, the modest clinical anticancer activity of rapalogues, which preferentially inhibit mTOR complex 1, in most types of…
article
PCR In-Depth Focus 2013
In this PCR In-Depth Focus: Challenges for qRT-PCR in detecting / quantifying microRNA in vitro and in vivo; Emerging clinical applications of digital PCR; Workshop Preview: Advanced 3d cell based assays, preparation, analysis and troubleshooting...
news
Bristol-Myers Squibb and Emory University announce partnership
21 June 2012 | By Bristol-Myers Squibb Company
First studies under the agreement to focus on clinical trial programs in oncology...
